Ying-Cheng Chiang

15PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersTumour immunologyGlycoconjugatesMedical biotechnology diagnostics (incl. biosensors)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 08, 2026
Spatial transcriptomic profiling of ovarian clear cell carcinoma reveals heterogeneity in OXPHOS and EMT gradients.

|Dec 31, 2025
BTLA: An Emerging Immune Checkpoint Target in Cancer Immunotherapy.

Ming-Cheng Chang, Wan-Chi Lee, Yi-Jou Tai

|Dec 19, 2025
Association of homologous recombination repair gene mutation with clinical prognosis in histological subtypes of epithelial ovarian cancer patients.

Yen-Han Wang, Heng-Cheng Hsu, Po-Han Lin

|Jul 29, 2025
Development of INER-PP-F11N as the Peptide-Radionuclide Conjugate Drug Against CCK2 Receptor-Overexpressing Tumors.

Ming-Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang

|Jan 08, 2025
Iodine-123 Metaiodobenzylguanidine (I-123 MIBG) in Clinical Applications: A Comprehensive Review.

Ming-Cheng Chang, Cheng-Liang Peng, Chun-Tang Chen

|Mar 28, 2024
The Role of Chitinase-3-like Protein-1 (YKL40) in the Therapy of Cancer and Other Chronic-Inflammation-Related Diseases.

Ming-Cheng Chang, Chun-Tang Chen, Ping-Fang Chiang

Pageof 3

Frequent Collaborators

7 joint publications

Yi-Jou Tai

6 joint publications

Heng-Cheng Hsu

3 joint publications

Wen-Fang Cheng

3 joint publications

Ming-Cheng Chang